| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |